Liposomes Composed by Membrane Lipid Extracts from Macrophage Cell Line as a Delivery of the Trypanocidal N,N'-Squaramide 17 towards Trypanosoma cruzi.
Christian Rafael QuijiaCínthia Caetano BonattoLuciano Paulino SilvaMilene Aparecida AndradeClenia Santos AzevedoCamila Lasse SilvaManel VegaJaime Martins de SantanaIzabela Marques Dourado BastosMarcella Lemos Brettas CarneiroPublished in: Materials (Basel, Switzerland) (2020)
Chagas is a neglected tropical disease caused by Trypanosoma cruzi, and affects about 25 million people worldwide. N, N'-Squaramide 17 (S) is a trypanocidal compound with relevant in vivo effectiveness. Here, we produced, characterized, and evaluated cytotoxic and trypanocidal effects of macrophage-mimetic liposomes from lipids extracted of RAW 264.7 cells to release S. As results, the average hydrodynamic diameter and Zeta potential of mimetic lipid membranes containing S (MLS) was 196.5 ± 11 nm and -61.43 ± 2.3 mV, respectively. Drug entrapment efficiency was 73.35% ± 2.05%. After a 72 h treatment, MLS was observed to be active against epimastigotes in vitro (IC50 = 15.85 ± 4.82 μM) and intracellular amastigotes (IC50 = 24.92 ± 4.80 μM). Also, it induced low cytotoxicity with CC50 of 1199.50 ± 1.22 μM towards VERO cells and of 1973.97 ± 5.98 μM in RAW 264.7. MLS also induced fissures in parasite membrane with a diameter of approximately 200 nm in epimastigotes. MLS showed low cytotoxicity in mammalian cells and high trypanocidal activity revealing this nanostructure a promising candidate for the development of Chagas disease treatment.
Keyphrases
- trypanosoma cruzi
- induced apoptosis
- cell cycle arrest
- high glucose
- adipose tissue
- photodynamic therapy
- drug induced
- systematic review
- diabetic rats
- fatty acid
- cell death
- signaling pathway
- climate change
- endoplasmic reticulum stress
- emergency department
- replacement therapy
- endothelial cells
- reactive oxygen species
- human health
- smoking cessation
- anti inflammatory